Protalix BioTherapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Protalix BioTherapeutics, Inc. (PLX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.38 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-18
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.38M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.40M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.50M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.41M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.38M 10-K · filed 2026-03-18 |
| 2025-09-30 | $1.40M 10-Q · filed 2025-11-13 |
| 2024-12-31 | $1.50M 10-K · filed 2025-03-17 |
| 2023-12-31 | $1.41M 10-K · filed 2024-03-14 |
| 2022-12-31 | $1.12M 10-K · filed 2023-02-27 |
| 2021-12-31 | $1.21M 10-K · filed 2022-03-31 |
| 2020-12-31 | $1.23M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |